Skip to main content
FinSpry Logo
FinSpry
GILD logo
GILD
(NASDAQ)
Gilead Sciences, Inc.
$130.86-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Gilead Sciences (GILD) Stock Price & Financial Analysis

Gilead Sciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$127.61 - $131.07
52-Week High$157.29
52-Week Low$107.75
Open$129.22
Volume6.30M
Average Volume (3M)7.86M
Market Cap163.45B
Shares Outstanding1.25B
P/E Ratio (TTM)18.55
Forward P/E12.00
Price to Sales (P/S)5.75
Price to Book (P/B)7.27
EV/EBITDA13.43
Revenue (TTM)29.73B
Net Income (TTM)9.22B
Free Cash Flow (TTM)10.23B
EPS (TTM)$7.35
Profit Margin30.99%
Operating Margin38.83%
Return on Equity (ROE)39.19%
Debt to Equity0.94
50-Day MA$129.98
200-Day MA$130.94
52-Week Change25.28%
Annual Dividend$3.22
Dividend Yield2.36%
Payout Ratio43.81%
Last Dividend Ex-DateJun 15, 2026

Frequently Asked Questions About Gilead Sciences

What is the current stock price for GILD?

As of the latest trading session, GILD stock trades at $130.86. The 52-week range is $107.75–$157.29, with a day range of $127.61–$131.07.

What is the P/E ratio for GILD?

Gilead Sciences's trailing P/E ratio is 18.6, meaning investors pay $18.6 for every $1 of annual earnings. The forward P/E is 12.0, reflecting analyst expectations for future earnings. Gilead Sciences operates in the Healthcare sector.

Does GILD pay dividends?

Yes, Gilead Sciences pays a 2.36% annual dividend yield ($3.22 per share). The payout ratio is 43.8%. The last ex-dividend date was 2026-06-15.

What do analysts recommend for GILD?

Based on 26 analysts, the consensus for GILD is Buy.

What is the market cap of GILD?

Gilead Sciences's market capitalization is $164.10B, classifying it as a large-cap company. Gilead Sciences operates in the Healthcare sector within the Drug Manufacturers - General industry.